Chennai Man Who Took Part in ‘Covidshield’ Vaccine Trial Alleges Neuro Breakdown, Seeks Rs 5 Crore Compensation

Articles Educational News News
Share now on social media

Alleging that the candidate vaccine was not safe, he has also sought cancelling approval for its testing, ‘manufacture and distribution’, failing which legal action would be taken.

CHENNAI: In a major drawback to the aspirations of a quick vaccine against the coronavirus, a 40-year-old man who took part in the ‘Covidshield’ vaccine trial here has alleged serious side effects, including a virtual neurological breakdown and impairment of cognitive functions.

He has sought a compensation of Rs five crore in a legal notice to the Serum Institute of India and others, besides seeking a halt to the Oxford-Astra Zeneca vaccine trial. Also Read.

Alleging that the candidate vaccine was not safe, he has also sought cancelling approval for its testing, ‘manufacture and distribution’, failing which legal action would be taken.

The legal notice has been sent to Pune based Serum Institute of India (SII), which has collaborated with Oxford University and Astra Zeneca, a pharmaceutical company, in connection with making of the vaccine, ‘Covidshield.’

The Indian Council of Medical Research, one of the sponsors besides SII, and Sri Ramachandra Institute of Higher Education and Research, which administered the vaccine to the man, have been served with the notice.

The Drugs Controller General of India and the institutional ethics committee at the implementation site are investigating if the adverse event as claimed to have been suffered by a COVID-19 vaccine trial participant are related to the shot administered to him.


Share now on social media